Tendon and ligament injuries: The genetic component

British Journal of Sports Medicine

Volumn 41, Issue 4, 2007, Pages 241-246

  September, Alison V ^a   Schwellnus, Martin P ^a   Collins, Malcolm ^a,b  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN FIBER; COLLAGEN TYPE 5; COLLAGEN TYPE 5 ALPHA 1; TENASCIN; UNCLASSIFIED DRUG;

ACHILLES TENDINITIS; ACHILLES TENDON RUPTURE; ANTERIOR CRUCIATE LIGAMENT INJURY; CLINICAL FEATURE; DNA POLYMORPHISM; GENE EXPRESSION; GENE INTERACTION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HAPLOTYPE; HIGH RISK POPULATION; HUMAN; LIGAMENT INJURY; NUCLEOTIDE SEQUENCE; REVIEW; RISK ASSESSMENT; RISK FACTOR; ROTATOR CUFF; ROTATOR CUFF RUPTURE; SINGLE NUCLEOTIDE POLYMORPHISM; TENDON INJURY; ACHILLES TENDON; ANTERIOR CRUCIATE LIGAMENT; GENETICS; INJURY; KNEE INJURY; LIGAMENT;

ACHILLES TENDON; ANTERIOR CRUCIATE LIGAMENT; HUMANS; KNEE INJURIES; LIGAMENTS, ARTICULAR; RISK FACTORS; ROTATOR CUFF; TENASCIN; TENDON INJURIES;

EID: 34250685323     PISSN: 03063674     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjsm.2006.033035     Document Type: Review

References (72)

1. Harvie P, Ostlere SJ, Teh J, et al. Genetic influences in the aetiology of tears of the rotator cuff. Sibling risk of a full-thickness tear. J Bone Joint Surg Br 2004;86:696-700.
2. Woo SL, Abramowitch SD, Kilger R, et al. Biomechanics of knee ligaments: injury, healing, and repair. J Biomech 2006;39:1-20.
3. Rees JD, Wilson AM, Wolman RL. Current concepts in the management of tendon disorders. Rheumatology 2006;45:508-21.
4. Jarvinen TA, Kannus P, Maffulli N, et al. Achilles tendon disorders: etiology and epidemiology. Foot Ankle Clin 2005;10:255-66.
5. Mazzone MF, McCue T. Common conditions of the Achilles tendon. Am Fam Physician 2002;65:1805-10.
6. Beynnon BD, Johnson RJ, Abate JA, et al. Treatment of anterior cruciate ligament injuries, part I. Am J Sports Med 2005;33:1579-602.
7. Puddu G, Ippolito E, Postacchini F. A classification of Achilles tendon disease. Am J Sports Med 1976;4:145-50.
8. Barr KP. Rotator cuff disease. Phys Med Rehabil Clin N Am 2004;15:475-91.
9. Tytherleigh-Strong G, Hirahara A, Miniaci A. Rotator cuff disease. Curr Opin Rheumatol 2001;13:135-45.
10. Gomoll AH, Katz JN, Warner JJ, et al. Rotator cuff disorders: recognition and management among patients with shoulder pain. Arthritis Rheum 2004;50:3751-61.
11. Almekinders LC. Tendinitis and other chronic tendinopathies. J Am Acad Orthop Surg 1998;6:157-64.
12. Schepsis AA, Jones H, Haas AL. Achilles tendon disorders in athletes. Am J Sports Med 2002;30:287-305.
13. Kannus P, Jarvinen TL, Jarvinen TA, et al. Painful Achilles tendon and its treatment. Scand J Med Sci Sports 2004;14:69-71.
14. Riley G. The pathogenesis of tendinopathy. A molecular perspective. Rheumatology 2004;43:131-42.
15. Childs SG. Pathogenesis of anterior cruciate ligament injury. Orthop Nurs 2002;21:35-40.
16. Bahr R, Krosshaug T. Understanding injury mechanisms: a key component of preventing injuries in sport. Br J Sports Med 2005;39:324-9.
17. Hewett TE, Myer GD, Ford KR. Anterior cruciate ligament injuries in female athletes: Part 1, Mechanisms and risk factors. Am J Sports Med 2006;34:299-311.
18. Matava MJ, Purcell DB, Rudzki JR. Partial-thickness rotator cuff tears. Am J Sports Med 2005;33:1405-17.
19. Kannus P, Natri A. Etiology and pathophysiology of tendon ruptures in sports. Scand J Med Sci Sports 1997;7:107-12.
20. Flynn RK, Pedersen CL, Birmingham TB, et al. The familial predisposition toward tearing the anterior cruciate ligament: a case control study. Am J Sports Med 2005;33:23-8.
21. Prockop DJ, Chu ML, de Wet W, et al. Mutations in osteogenesis imperfecta leading to the synthesis of abnormal type I procollagens. Ann N Y Acad Sci 1985;460:289-97.
22. De Paepe A, Nuytinck L, Hausser I, et al. Mutations in the COL5A1 gene are causal in the Ehlers-Danlos Syndromes I and II. Am J Hum Genet 1997;60:547-54.
23. Judge DP, Dietz HC. Marfan's syndrome. Lancet 2005;366:1965-76.
24. Dawn TM, Barrett JH. Genetic linkage studies. Lancet 2005;366:1036-44.
25. Ala-Kokko L. Genetic risk factors for lumbar disc disease. Ann Med 2002;34:42-7.
26. Tilkeridis C, Bei T, Garantziotis S, et al. Association of a COL1A1 polymorphism with lumbar disc disease in young military recruits. J Med Genet 2005;42:e44.
27. Noponen-Hietala N, Kyllonen E, Mannikko M, et al. Sequence variations in the collagen IX and XI genes are associated with degenerative lumbar spinal stenosis. Ann Rheum Dis 2003;62:1208-14.
28. Solovieva S, Kouhia S, Leino-Arjas P, et al. Interleukin 1 polymorphisms and intervertebral disc degeneration. Epidemiology 2004;15:626-33.
29. Solovieva S, Lohiniva J, Leino-Arjas P, et al. COL9A3 gene polymorphism and obesity in intervertebral disc degeneration of the lumbar spine: evidence of gene-environment interaction. Spine 2002;27:2691-6.
30. Jozsa L, Balint JB, Kannus P, et al. Distribution of blood groups in patients with tendon rupture. J Bone Joint Surg Br 1989;71-B:272-4.
31. Kujala UM, Jarvinen M, Natri A, et al. ABO blood groups and musculoskeletal injuries. Injury 1992;23:131-3.
32. Aroen A, Helgo D, Granlund OG, et al. Contralateral tendon rupture risk is increased in individuals with a previous Achilles tendon rupture. Scand J Med Sci Sports 2004;14:30-3.
33. Mahrlein R, Schmelzeisen H, Papathanassopoulos A. Achillessehnenrupturen und blutgruppenzugehorigkeit. Aktuelle Traumatol 1995;25:13-15.
34. Leppilahti J, Puranen J, Orava S. ABO blood group and Achilles tendon rupture. Ann Chir Gynaecol 1996;85:369-71.
35. Maffulli N, Reaper JA, Waterston SW, et al. ABO blood groups and Achilles tendon rupture in the Grampian region of Scotland. Clin J Sport Med 2000;10:269-71.
36. Mokone GG. Risk factors for Achilles tendon injuries: an emphasis on the identification of specific genetic factors. South Africa: University of Cape Town, 2006.
37. Bennett EP, Steffensen R, Clausen H, et al. Genomic cloning of the human histoblood group ABO locus. Biochem Biophys Res Commun 1995;206:18-25.
38. Maffulli N, Kader D. Tendinopathy of tendo Achillis. J Bone Joint Surg Br 2002;84:1-8.
39. September AV, Mokone GG, Schwellnus MP, et al. Genetic risk factors for Achilles tendon injuries. Int Sports Med J 2006;7:201-15.
40. Ireland D, Harrall R, Curry V, et al. Multiple changes in gene expression in chronic human Achilles tendinopathy. Matrix Biol 2001;20:159-69.
41. Alfredson H, Lorentzon M, Backman S, et al. cDNA-arrays and real-time quantitative PCR techniques in the investigation of chronic Achilles tendinosis. J Orthop Res 2003;21:970-5.
42. Mokone GG, Gajjar M, September AV, et al. The Guanine-thymine dinucleotide repeat polymorphism within the tenascin-C gene is associated with Achilles tendon injuries. Am J Sports Med 2005;33:1016-21.
43. Mokone GG, Schwellnus MP, Noakes TD, et al. The COL5A1 gene and Achilles tendon pathology. Scand J Med Sci Sports 2006;16:19-26.
44. Palmer LJ, Cardon LR. Shaking the tree: mapping complex disease genes with linkage disequilibrium. Lancet 2005;366:1223-34.
45. Feuk L, Carson AR, Scherer SW. Structural variation in the human genome. Nat Rev Genet 2006;7:85-97.
46. Aldred PM, Hollox EJ, Armour JA. Copy number polymorphism and expression level variation of the human alpha-defensin genes DEFA1 and DEFA3. Hum Mol Genet 2005;14:2045-52.
47. Linzmeier RM, Ganz T. Copy number polymorphisms are not a common feature of innate immune genes. Genomics 2006;88:122-6.
48. Freeman JL, Perry GH, Feuk L, et al. Copy number variation: new insights in genome diversity. Genome Res 2006;16:949-61.
49. Jarvinen TA, Kannus P, Jarvinen TL, et al. Tenascin-C in the pathobiology and healing process of musculoskeletal tissue injury. Scand J Med Sci Sports 2000;10:376-82.
50. Jarvinen TA, Jozsa L, Kannus P, et al. Mechanical loading regulates tenascin-C expression in the osteotendinous junction. J Cell Sci 1999;112:3157-66.
51. Jarvinen TA, Jozsa L, Kannus P, et al. Mechanical loading regulates the expression of tenascin-C in the myotendinous junction and tendon but does not induce de novo synthesis in the skeletal muscle. J Cell Sci 2003;116:857-66.
52. Jones FS, Jones PL. The tenascin family of ECM glycoproteins: structure, function, and regulation during embryonic development and tissue remodeling. Dev Dyn 2000;218:235-59.
53. Smith M, Simpson NE. Report of the committee on the genetic constitution of chromosomes 9 and 10. Cytogenet Cell Genet 1989;51:202-25.
54. Greenspan DS, Byers MG, Eddy RL, et al. Human collagen gene COL5A1 maps to the q34.2-q34.3 region of chromosome 9, near the locus for Nail-Patella syndrome. Genomics 1992;12:836-7.
55. Birk DE. Type V collagen: heterotypic type I/V collagen interactions in the regulation of fibril assembly. Micron 2001;32:223-37.
56. Birk DE, Fitch JM, Babiarz JP, et al. Collagen fibrillogenesis in vitro: interaction of types I and V collagen regulates fibril diameter. J Cell Sci 1990;95:649-57.
57. Matsuda A, Hirota T, Akahoshi M, et al. Coding SNP in tenascin-C Fn-III-D domain associates with adult asthma. Hum Mol Genet 2005;14:2779-86.
58. Boot-Handford RP, Tuckwell DS, Plumb DA, et al. A novel and highly conserved collagen (pro(alpha)1(XXVII)) with a unique expression pattern and unusual molecular characteristics establishes a new clade within the vertebrate fibrillar collagen family. J Biol Chem 2003;278:31067- 77.
59. Pace JM, Corrado M, Missero C, et al. Identification, characterization and expression analysis of a new fibrillar collagen gene, COL27A1. Matrix Biol 2003;22:3-14.
60. Jenkins E, Moss JB, Pace JM, et al. The new collagen gene COL27A1 contains SOX9-responsive enhancer elements. Matrix Biol 2005;24:177-84.
61. Riley G. Chronic tendon pathology: molecular basis and therapeutic implications. Expert Rev Mol Med 2005;7:1-25.
62. Young BB, Zhang G, Koch M, et al. The roles of types XII and XIV collagen in fibrillogenesis and matrix assembly in the developing cornea. J Cell Biochem 2002;87:208-20.
63. Thomopoulos S, Hattersley G, Rosen V, et al. The localized expression of extracellular matrix components in healing tendon insertion sites: an in situ hybridization study. J Orthop Res 2002;20:454-63.
64. Riley GP. Gene expression and matrix turnover in overused and damaged tendons. Scand J Med Sci Sports 2005;15:241-51.
65. Kaushal GP, Shah SV. The new kids on the block: ADAMTSs, potentially multifunctional metalloproteinases of the ADAM family. J Clin Invest 2000;105:1335-7.
66. Murrell GA. Understanding tendinopathies. Br J Sports Med 2002;36:392-3.
67. Giunta C, Nuytinck L, Raghunath M, et al. Homozygous Gly530Ser substitution in COL5A1 causes mild classical Ehlers-Danlos syndrome. Am J Med Genet 2002;109:284-90.
68. Schalkwijk J, Zweers MC, Steijlen PM, et al. A recessive form of the Ehlers-Danlos syndrome caused by tenascin-X deficiency. N Engl J Med 2001;345:1167-75.
69. Matziolis G, Drahn T, Perka C. Spontaneous patellar tendon rupture in a patient with Ehlers-Danlos syndrome). Unfallchirurg 2003;106:1051-3.
70. Palmeri S, Mari F, Meloni I, et al. Neurological presentation of Ehlers-Danlos syndrome type IV in a family with parental mosaicism. Clin Genet 2003;63:510-15.
71. Palvolgyi R, Balint BJ, Jozsa L. The Ehlers-Danlos syndrome causing lacerations in tendons and muscles. Arch Orthop Trauma Surg 1979;95:173-6.
72. Hildebrand KA, Frank CB, Hart DA. Gene intervention in ligament and tendon: current status, challenges, future directions. Gene Ther 2004;11:368-78.